Fig. 1From: Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trialsPatient disposition in (a) the ZEUS study (b) the HERAKLES study (safety populations). PTDM, posttransplant diabetes mellitusBack to article page